Clinical Trials Directory

Trials / Unknown

UnknownNCT03734835

The Effect of Supplementation of Flaxseed, Hesperidin, Flaxseed and Hesperidin Together in Metabolic Syndrome

The Effect of Supplementation of Flaxseed, Hesperidin, Flaxseed and Hesperidin Together in Metabolic Syndrome and Its Components: A Randomized, Controlled Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
National Nutrition and Food Technology Institute · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

To study the effects of Hesperidin, flaxseed and both together in patients with metabolic syndrome, 100 patients will be randomly allocated to one of following four groups: control group, hesperidin group (2 capsules Hesperidin), flaxseed group (30 gram flaxseed) or flaxseed-hesperidin group (2 capsules Hesperidin and 30 gram flaxseed) for 12 weeks; both groups will be advised to adherence the investigators' diet and exercise program too. At the first and the end of the intervention, metabolic factors will be assessed and compared between groups.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENThesperidin1000 mg hesperidin as two capsules
DIETARY_SUPPLEMENThesperidin and flaxseed1000 mg hesperidin as two capsules and 30 grams flaxseed
DIETARY_SUPPLEMENTflaxseed30 grams flaxseed
OTHERcontrolno supplementation

Timeline

Start date
2018-04-01
Primary completion
2019-02-01
Completion
2019-03-01
First posted
2018-11-08
Last updated
2018-11-08

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT03734835. Inclusion in this directory is not an endorsement.